At Total Analysis, we are driven by a singular vision:
to revolutionize pathogen detection and identification, making it faster, more accurate, and accessible.
Founded by Dr. Darrell Marshall, Total Analysis stands at the forefront of bioanalytical technology.
Introducing Our Next-Generation Pathogen Detection Device In our quest to redefine the boundaries of scientific innovation, we have crafted a pathogen detection device that encapsulates the essence of precision and simplicity. With our pioneering integration of unique ionization technology and ion mobility spectrometry, we are pushing the limits of what is possible in pathogen detection. (Read More)
At Total Analysis, we are not merely creating products; we are engineering a safer, healthier future. Our pathogen detection device transcends traditional technology - it is a beacon of our dedication to pioneering innovations that significantly enhance health and community welfare.
Meet the team that makes it all possible.
Dr. Darrell D. Marshall, Ph.D.
Founder & CEO
combines 15 years of expertise in Bioanalytical Chemistry, systems biology, and infectious diseases, with significant innovations in cancer screening and bacterial identification tools. He leads the company's strategic research and development efforts.
Dr. Fatema Bhinderwala, Ph.D.
CFO
with a strong foundation in Chemistry and over 20 scholarly publications, Dr.Bhinderwala excels in large molecule characterization and advanced analytical methodologies.She directs the optimization of extraction protocols and instrumentation at Total Analysis.
Kristin Klaus, MBA
COO
with a 15-year background in Sales and Business Development, Kristin has crafted strategic approaches that enhance diagnostic solutions, significantly boosting patient outcomes and practice ROIs across the nation.